Clinical Trial Update: LUNAR-4: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Tumor Treating Fields (TTFields) at 150 kHz in combination with pembrolizumab for metastatic non-small cell lung cancer; the study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pembrolizumab (Keytruda) (pembrolizumab)

Snippet

Sponsor: NovoCure GmbH | Conditions: Non-Small Cell Lung Cancer (NSCLC) | Phase 2 | Status: ACTIVE_NOT_RECRUITING